Philip Robinson

13.0k citations

334 papers · 8.6k indexed · 2 hit papers · h-index 46

Impact in

Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Pulmonary and Respiratory Medicine top 0.5%
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Tracheal and airway disorders

Papers in

Pulmonary and Respiratory Medicine 133
- Cystic Fibrosis Research Advances 81
- Neonatal Respiratory Health Research 45
- Tracheal and airway disorders 38
Hepatology 28
- Hepatocellular Carcinoma Treatment and Prognosis 24
- Liver Disease and Transplantation 12

Co-authors: Peter D. Sly Janice Ward Sarath Ranganathan Colin Robertson J. Ashley Guthrie Stephen M. Stick L Kreel Conor Murray
Journals: Pediatric Pulmonology (14 papers)Clinical Radiology (12 papers)British Journal of Radiology (12 papers)Journal of Cystic Fibrosis (11 papers)American Journal of Respiratory and Critical Care Medicine (11 papers)
Partner nations: United Kingdom Australia France

In The Last Decade

Philip Robinson

322 papers receiving 8.3k citations

Hit Papers

align trajectories log scale

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele 2023 · 74 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 American Journal of Respiratory and Critical Care Medicine
2009 American Journal of Respiratory and Critical Care Medicine

Peers

Countries citing papers authored by Philip Robinson

Since Specialization

Citations

This map shows the geographic impact of Philip Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Robinson more than expected).

Fields of papers citing papers by Philip Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Robinson. The network helps show where Philip Robinson may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Robinson Line = papers co-authored together Philip Robinson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Contemporary seasonal human coronaviruses display differences in cellular tropism compared to laboratory-adapted reference strains Journal of Virology ·Matthew J. Gartner, Monique L. Smith, Clyde Dapat, Y‐F Liaw, Thomas Tran, Mitra Jokar, Joseph Chen, Guizhi Sun, G Zimmerman, George Taiaroa, Michael J. Roche, Wen Shi Lee, Philip Robinson, José M. Polo, Kanta Subbarao, Jessica A. Neil	2025	1
2	Wide Spectrum of Disease Manifestations in Siblings With Primary Ciliary Dyskinesia Carrying DNAJB13 Mutations: A Case Study Journal of Paediatrics and Child Health ·Mitra Jokar, O. Baron, Paul Martinello, 杏奈貞安, Philip Robinson	2025	0
3	Proteostasis as a fundamental principle of Tau immunotherapy Brain ·Esteban Cruz, Rebecca M. Nisbet, Pranesh Padmanabhan, Ashley J. Waardenberg, Mark E. Graham, T. Yagi, Adis Sefhira, Tamer EREN, Philip Robinson, Jürgen Götz	2024	2
4	Heterozygous cis HYDIN mutations cause primary ciliary dyskinesia Med ·Mitra Jokar, Paul Martinello, Vicki Bennett‐Wood, Philip Robinson	2024	2
5	Priorities and barriers for research related to primary ciliary dyskinesia ERJ Open Research ·Myrofora Goutaki, Ken Auberry, Bruna Rubbo, James D. Chalmers, Panayiotis Κouis, Isabel Martins Guillen, Jean‐François Papon, Johanna Raidt, Philip Robinson, Laura Behan, Jane S. Lucas	2024	1
6	Otolaryngological burden of disease in children with primary ciliary dyskinesia in Victoria, Australia International Journal of Pediatric Otorhinolaryngology ·Diana Chen, Nicholas Burridge, 博之金城, Philip Robinson	2023	2
7	A novel treatment to enhance survival for end stage triple negative breast cancer using repurposed veterinary anthelmintics combined with gut‑supporting/immune enhancing molecules Oncology Reports ·Vijaya Iragavarapu‐Charyulu, D. R. Causton, Philip Robinson, Esther A. Guzmán, M. Kurt, Louis Pereira, Ceylan Isgor	2023	1
8	Nasal nitric oxide measurement in children for the diagnosis of primary ciliary dyskinesia: European Respiratory Society technical standard European Respiratory Journal ·Nicole Beydon, Panayiotis Κouis, June K. Marthin, Philipp Latzin, E. Miggiani, Stephanie D. Davis, Eric G. Haarman, Amanda Harris, Claire Hogg, 贺佟佟 HE Tongtong, Claudia E. Kuehni, Diana Marangu, Kim G. Nielsen, M Girola, Philip Robinson, Nisreen Rumman, Matthew D. Rutter, Woolf T. Walker, Thomas W. Ferkol, Jane S. Lucas	2023	24
9	Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele American Journal of Respiratory and Critical Care Medicine ·Jennifer L. Goralski, Jordana E. Hoppe, Marcus Mall, Susanna A. McColley, Edward F. McKone, Maher Mary Lou, Jonathan H. Rayment, Philip Robinson, Florian Stehling, Jennifer L. Taylor‐Cousar, Elizabeth Tullis, Neil Ahluwalia, Anna Chin, Chenghao Chu, Mengdi Lu, Tao Niu, Tanya G. Weinstock, Félix Ratjen, Margaret Rosenfeld Hit paper breakdown →	2023	74
10	An international survey on nasal nitric oxide measurement practices for the diagnosis of primary ciliary dyskinesia ERJ Open Research ·Nicole Beydon, Thomas W. Ferkol, Amanda Harris, E. Miggiani, Stephanie D. Davis, Eric G. Haarman, Claire Hogg, 贺佟佟 HE Tongtong, Panayiotis Κouis, Claudia E. Kuehni, Philipp Latzin, Diana Marangu, June K. Marthin, Kim G. Nielsen, Philip Robinson, Nisreen Rumman, 李政辉, Woolf Walker, Jane S. Lucas	2022	4
11	Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells Viruses ·Leo Lee, Mitra Jokar, V.V. Shabakova, Vera Ignjatović, Damian F. J. Purcell, Philip Robinson, Craig J. Morton, Michael W. Parker, Gary P. Anderson, Paul Monagle, Kanta Subbarao, Jessica A. Neil	2022	8
12	Pulmonary Mycobacterium abscessus complex in children with cystic fibrosis: A practical management guideline Journal of Paediatrics and Child Health ·Tiziana Bufacchi, Tom Connell, Philip Robinson, Nigel Curtis, John Massie, Colin Robertson, Joanne Harrison, Shivanthan Shanthikumar, Penelope A Bryant, Mike Starr, Andrew C. Steer, Sarath Ranganathan, Amanda Gwee	2019	12
13	VENTILATION MEASUREMENTS FROM HYPERPOLARIZED 3HE MAGNETIC RESONANCE IMAGING ARE A MARKER OF AIRWAY CLOSURE IN SUBJECTS WITH AIRFLOW OBSTRUCTION Respirology ·栄二渡部, Bruce Thompson, Benjamin Harris, Gary Cowin, Philip Robinson, Ihsan Subhan Ullah	2019	1
14	Effects of Segregation on an Epidemic Pseudomonas aeruginosa Strain in a Cystic Fibrosis Clinic American Journal of Respiratory and Critical Care Medicine ·Amanda Griffiths, Kris M. Jamsen, John B. Carlin, Keith Grimwood, Rosemary Carzino, Philip Robinson, John Massie, David Armstrong	2005	66
15	Indeterminate liver lesions in cancer Cancer Imaging ·Philip Robinson	2002	6
16	Increased Airway Responsiveness and Decreased Alveolar Attachment Points Following in Utero Smoke Exposure in the Guinea Pig American Journal of Respiratory and Critical Care Medicine ·John Elliot, Neil Carroll, Renee Johnston, M.A. Wolf, Philip Robinson	2001	45
17	Beaumarchais : homme de lettres, homme de société Peter Lang eBooks ·Philip Robinson	2000	0
18	Evangelista Torricelli The Mathematical Gazette ·Philip Robinson	1994	6
19	Prospective comparison of three non-invasive tests for pancreatic disease. BMJ ·川井力, C.J. Mitchell, Jing Feng, I. Hamilton, Henry Irving, J. Kelleher, D.J. Lintott, Philip Robinson, A. T. R. Axon, M.S. Losowsky	1984	27
20	Microangiopathic haemolytic anaemia. BMJ ·Dmitriy Shkrum, Philip Robinson, C. H. Poppe, 周燚炎	1970	4

About Philip Robinson

Philip Robinson is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Otorhinolaryngology, Sensory Systems and Toxicology, having authored 334 papers that have together received 8.6k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (81 papers), Neonatal Respiratory Health Research (45 papers), Tracheal and airway disorders (38 papers), Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Liver Disease Diagnosis and Treatment (18 papers), MRI in cancer diagnosis (13 papers), Respiratory viral infections research (13 papers) and Liver Disease and Transplantation (12 papers). The work is most often cited by research in Hepatology (1.1k citations), Pulmonary and Respiratory Medicine (3.8k citations), Otorhinolaryngology (300 citations), Radiology, Nuclear Medicine and Imaging (1.0k citations) and Sensory Systems (207 citations). Philip Robinson has collaborated with scholars based in United Kingdom, Australia and France. Frequent co-authors include Peter D. Sly, Janice Ward, Sarath Ranganathan, Colin Robertson, J. Ashley Guthrie, Stephen M. Stick, L Kreel, Conor Murray, Nicholas Moore and Nicholas de Klerk. Their work appears in journals such as Pediatric Pulmonology, Clinical Radiology, British Journal of Radiology, Journal of Cystic Fibrosis and American Journal of Respiratory and Critical Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact